Cargando…

Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data

The effects of common antidepressants on suicidal ideation (SI) is unclear. In the landmark STAR*D trial antidepressants were effective for Major Depressive Disorder (MDD) in early treatment phases, but less effective in later phases. The effects of antidepressants on SI across the entire sample of...

Descripción completa

Detalles Bibliográficos
Autores principales: Weissman, Cory R., Hadas, Itay, Yu, Dengdeng, Jones, Brett, Kong, Dehan, Mulsant, Benoit H., Blumberger, Daniel M., Daskalakis, Zafiris J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819691/
https://www.ncbi.nlm.nih.gov/pubmed/33479508
http://dx.doi.org/10.1038/s41386-020-00953-9
_version_ 1783639051800150016
author Weissman, Cory R.
Hadas, Itay
Yu, Dengdeng
Jones, Brett
Kong, Dehan
Mulsant, Benoit H.
Blumberger, Daniel M.
Daskalakis, Zafiris J.
author_facet Weissman, Cory R.
Hadas, Itay
Yu, Dengdeng
Jones, Brett
Kong, Dehan
Mulsant, Benoit H.
Blumberger, Daniel M.
Daskalakis, Zafiris J.
author_sort Weissman, Cory R.
collection PubMed
description The effects of common antidepressants on suicidal ideation (SI) is unclear. In the landmark STAR*D trial antidepressants were effective for Major Depressive Disorder (MDD) in early treatment phases, but less effective in later phases. The effects of antidepressants on SI across the entire sample of the STAR*D trial has never been investigated. We performed a secondary analysis of the STAR*D data with the primary outcome of change in score on the suicide item (item three) of the Hamilton Rating Scale for Depression (HRSD(17)) across all four study levels. We used descriptive statistics and logistic regression analyses. Pearson correlation was used for change in SI versus change in depression (HRSD(16)). Reduction in mean (SD) SI was greater in levels one: 0.29 (±0.78) (p < 0.001) and two: 0.26 (±0.88) (p < 0.001) than in levels three: 0.16 (±0.92) (p = 0.005) and four: 0.18 (±0.93) (p = 0.094). A history of past suicide attempts (OR 1.72, p = 0.007), comorbid medical illness (OR 2.23, p = 0.005), and a family history of drug abuse (OR 1.69, p = 0.008) were correlated with worsening of SI across level one. Treatment with bupropion (OR 0.24, p < 0.001) or buspirone (OR 0.24, p = 0.001) were correlated with lowering of SI across level two. Improvement in SI was correlated with improvement in overall depression (HRSD(16)) at level one: r(3756) = 0.48; level two: r(1027) = 0.38; level three: r(249) = 0.31; and level four: r(75) = 0.42 (p < 0.001 for all levels). Improvement in SI is limited with pharmacotherapy in patients with treatment-resistant depression. Treatments with known anti-suicidal effects in MDD, such as ECT, should be considered in these patients.
format Online
Article
Text
id pubmed-7819691
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78196912021-01-22 Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data Weissman, Cory R. Hadas, Itay Yu, Dengdeng Jones, Brett Kong, Dehan Mulsant, Benoit H. Blumberger, Daniel M. Daskalakis, Zafiris J. Neuropsychopharmacology Article The effects of common antidepressants on suicidal ideation (SI) is unclear. In the landmark STAR*D trial antidepressants were effective for Major Depressive Disorder (MDD) in early treatment phases, but less effective in later phases. The effects of antidepressants on SI across the entire sample of the STAR*D trial has never been investigated. We performed a secondary analysis of the STAR*D data with the primary outcome of change in score on the suicide item (item three) of the Hamilton Rating Scale for Depression (HRSD(17)) across all four study levels. We used descriptive statistics and logistic regression analyses. Pearson correlation was used for change in SI versus change in depression (HRSD(16)). Reduction in mean (SD) SI was greater in levels one: 0.29 (±0.78) (p < 0.001) and two: 0.26 (±0.88) (p < 0.001) than in levels three: 0.16 (±0.92) (p = 0.005) and four: 0.18 (±0.93) (p = 0.094). A history of past suicide attempts (OR 1.72, p = 0.007), comorbid medical illness (OR 2.23, p = 0.005), and a family history of drug abuse (OR 1.69, p = 0.008) were correlated with worsening of SI across level one. Treatment with bupropion (OR 0.24, p < 0.001) or buspirone (OR 0.24, p = 0.001) were correlated with lowering of SI across level two. Improvement in SI was correlated with improvement in overall depression (HRSD(16)) at level one: r(3756) = 0.48; level two: r(1027) = 0.38; level three: r(249) = 0.31; and level four: r(75) = 0.42 (p < 0.001 for all levels). Improvement in SI is limited with pharmacotherapy in patients with treatment-resistant depression. Treatments with known anti-suicidal effects in MDD, such as ECT, should be considered in these patients. Springer International Publishing 2021-01-21 2021-06 /pmc/articles/PMC7819691/ /pubmed/33479508 http://dx.doi.org/10.1038/s41386-020-00953-9 Text en © The Author(s), under exclusive licence to American College of Neuropsychopharmacology 2021
spellingShingle Article
Weissman, Cory R.
Hadas, Itay
Yu, Dengdeng
Jones, Brett
Kong, Dehan
Mulsant, Benoit H.
Blumberger, Daniel M.
Daskalakis, Zafiris J.
Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
title Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
title_full Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
title_fullStr Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
title_full_unstemmed Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
title_short Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data
title_sort predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the star*d data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819691/
https://www.ncbi.nlm.nih.gov/pubmed/33479508
http://dx.doi.org/10.1038/s41386-020-00953-9
work_keys_str_mv AT weissmancoryr predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata
AT hadasitay predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata
AT yudengdeng predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata
AT jonesbrett predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata
AT kongdehan predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata
AT mulsantbenoith predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata
AT blumbergerdanielm predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata
AT daskalakiszafirisj predictorsofchangeinsuicidalideationacrosstreatmentphasesofmajordepressivedisorderanalysisofthestarddata